Literature DB >> 29875246

Kaposi's Sarcoma-Associated Herpesvirus ORF68 Is a DNA Binding Protein Required for Viral Genome Cleavage and Packaging.

Matthew R Gardner1, Britt A Glaunsinger2,3,4.   

Abstract

Herpesviral DNA packaging into nascent capsids requires multiple conserved viral proteins that coordinate genome encapsidation. Here, we investigated the role of the ORF68 protein of Kaposi's sarcoma-associated herpesvirus (KSHV), a protein required for viral DNA encapsidation whose function remains largely unresolved across the herpesviridae. We found that KSHV ORF68 is expressed with early kinetics and localizes predominantly to viral replication compartments, although it is dispensable for viral DNA replication and gene expression. However, in agreement with its proposed role in viral DNA packaging, KSHV-infected cells lacking ORF68 failed to cleave viral DNA concatemers, accumulated exclusively immature B capsids, and released no infectious progeny virions. ORF68 has no predicted domains aside from a series of putative zinc finger motifs. However, in vitro biochemical analyses of purified ORF68 protein revealed that it robustly binds DNA and is associated with nuclease activity. These activities provide new insights into the role of KSHV ORF68 in viral genome encapsidation.IMPORTANCE Kaposi's sarcoma-associated herpesvirus (KSHV) is the etiologic agent of Kaposi's sarcoma and several B-cell cancers, causing significant morbidity and mortality in immunocompromised individuals. A critical step in the production of infectious viral progeny is the packaging of the newly replicated viral DNA genome into the capsid, which involves coordination between at least seven herpesviral proteins. While the majority of these packaging factors have been well studied in related herpesviruses, the role of the KSHV ORF68 protein and its homologs remains unresolved. Here, using a KSHV mutant lacking ORF68, we confirm its requirement for viral DNA processing and packaging in infected cells. Furthermore, we show that the purified ORF68 protein directly binds DNA and is associated with a metal-dependent cleavage activity on double-stranded DNA in vitro These activities suggest a novel role for ORF68 in herpesviral genome processing and encapsidation.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  DNA encapsidation; Kaposi's sarcoma-associated herpesvirus; herpesviruses; viral DNA processing

Mesh:

Substances:

Year:  2018        PMID: 29875246      PMCID: PMC6069193          DOI: 10.1128/JVI.00840-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Depletion of intracellular zinc and copper with TPEN results in apoptosis of cultured human retinal pigment epithelial cells.

Authors:  H J Hyun; J H Sohn; D W Ha; Y H Ahn; J Y Koh; Y H Yoon
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-02       Impact factor: 4.799

2.  Liquid-crystalline, phage-like packing of encapsidated DNA in herpes simplex virus.

Authors:  F P Booy; W W Newcomb; B L Trus; J C Brown; T S Baker; A C Steven
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

3.  Analysis of herpes simplex virus type 1 DNA packaging signal mutations in the context of the viral genome.

Authors:  Lily Tong; Nigel D Stow
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

4.  Properties of the protein encoded by the UL32 open reading frame of herpes simplex virus 1.

Authors:  Y E Chang; A P Poon; B Roizman
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

5.  The products of herpes simplex virus type 1 gene UL26 which are involved in DNA packaging are strongly associated with empty but not with full capsids.

Authors:  F J Rixon; A M Cross; C Addison; V G Preston
Journal:  J Gen Virol       Date:  1988-11       Impact factor: 3.891

6.  Signals for site-specific cleavage of HSV DNA: maturation involves two separate cleavage events at sites distal to the recognition sequences.

Authors:  S L Varmuza; J R Smiley
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

7.  Origin-independent assembly of Kaposi's sarcoma-associated herpesvirus DNA replication compartments in transient cotransfection assays and association with the ORF-K8 protein and cellular PML.

Authors:  F Y Wu; J H Ahn; D J Alcendor; W J Jang; J Xiao; S D Hayward; G S Hayward
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

8.  The putative herpes simplex virus 1 chaperone protein UL32 modulates disulfide bond formation during infection.

Authors:  Brandon S Albright; Athena Kosinski; Renata Szczepaniak; Elizabeth A Cook; Nigel D Stow; James F Conway; Sandra K Weller
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

9.  Cross-species conservation of episome maintenance provides a basis for in vivo investigation of Kaposi's sarcoma herpesvirus LANA.

Authors:  Aline C Habison; Marta Pires de Miranda; Chantal Beauchemin; Min Tan; Sofia A Cerqueira; Bruno Correia; Rajesh Ponnusamy; Edward J Usherwood; Colin E McVey; J Pedro Simas; Kenneth M Kaye
Journal:  PLoS Pathog       Date:  2017-09-14       Impact factor: 6.823

10.  Structure of the herpes simplex virus portal-vertex.

Authors:  Marion McElwee; Swetha Vijayakrishnan; Frazer Rixon; David Bhella
Journal:  PLoS Biol       Date:  2018-06-20       Impact factor: 8.029

View more
  9 in total

1.  Conserved CxnC Motifs in Kaposi's Sarcoma-Associated Herpesvirus ORF66 Are Required for Viral Late Gene Expression and Are Essential for Its Interaction with ORF34.

Authors:  Allison L Didychuk; Angelica F Castañeda; Lola O Kushnir; Carolyn J Huang; Britt A Glaunsinger
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

2.  The Interaction between ORF18 and ORF30 Is Required for Late Gene Expression in Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Angelica F Castañeda; Britt A Glaunsinger
Journal:  J Virol       Date:  2018-12-10       Impact factor: 5.103

3.  An integrative approach identifies direct targets of the late viral transcription complex and an expanded promoter recognition motif in Kaposi's sarcoma-associated herpesvirus.

Authors:  Divya Nandakumar; Britt Glaunsinger
Journal:  PLoS Pathog       Date:  2019-05-16       Impact factor: 6.823

Review 4.  Controlling the Revolving and Rotating Motion Direction of Asymmetric Hexameric Nanomotor by Arginine Finger and Channel Chirality.

Authors:  Peixuan Guo; Dana Driver; Zhengyi Zhao; Zhen Zheng; Chun Chan; Xiaolin Cheng
Journal:  ACS Nano       Date:  2019-05-28       Impact factor: 15.881

5.  A pentameric protein ring with novel architecture is required for herpesviral packaging.

Authors:  Allison L Didychuk; Stephanie N Gates; Matthew R Gardner; Lisa M Strong; Andreas Martin; Britt A Glaunsinger
Journal:  Elife       Date:  2021-02-08       Impact factor: 8.140

6.  Phase separation and DAXX redistribution contribute to LANA nuclear body and KSHV genome dynamics during latency and reactivation.

Authors:  Olga Vladimirova; Alessandra De Leo; Zhong Deng; Andreas Wiedmer; James Hayden; Paul M Lieberman
Journal:  PLoS Pathog       Date:  2021-01-20       Impact factor: 6.823

7.  WSV056 Inhibits Shrimp Nitric Oxide Synthase Activity by Downregulating Litopenaeus vannamei Sepiapterin Reductase to Promote White Spot Syndrome Virus Replication.

Authors:  Wei Wang; Qin Zheng; Chen Yu; Changkun Pan; Peng Luo; Jianming Chen
Journal:  Front Microbiol       Date:  2021-12-23       Impact factor: 5.640

8.  The Contribution of Kaposi's Sarcoma-Associated Herpesvirus ORF7 and Its Zinc-Finger Motif to Viral Genome Cleavage and Capsid Formation.

Authors:  Yuki Iwaisako; Tadashi Watanabe; Manami Futo; Rimiko Okabe; Yuichi Sekine; Youichi Suzuki; Takashi Nakano; Masahiro Fujimuro
Journal:  J Virol       Date:  2022-09-08       Impact factor: 6.549

9.  The Kaposi's Sarcoma-Associated Herpesvirus Protein ORF42 Is Required for Efficient Virion Production and Expression of Viral Proteins.

Authors:  Matthew Butnaru; Marta Maria Gaglia
Journal:  Viruses       Date:  2019-08-02       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.